| Report ID | 264317 |
| Drug Identification Number | 02535793 |
| Brand name | JAMP-AMOXICILLIN |
| Common or Proper name | Amoxicillin Powder for Oral Suspension |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | AMOXICILLIN |
| Strength(s) | 125MG |
| Dosage form(s) | POWDER FOR SUSPENSION |
| Route of administration | ORAL |
| Packaging size | 150 |
| ATC code | J01CA |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-08-01 |
| Estimated end date | 2026-02-06 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-01-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2026-01-12 | French | Compare |
| v9 | 2026-01-12 | English | Compare |
| v8 | 2025-12-11 | French | Compare |
| v7 | 2025-12-11 | English | Compare |
| v6 | 2025-10-29 | French | Compare |
| v5 | 2025-10-29 | English | Compare |
| v4 | 2025-09-22 | French | Compare |
| v3 | 2025-09-22 | English | Compare |
| v2 | 2025-08-04 | French | Compare |
| v1 | 2025-08-04 | English | Compare |
Showing 1 to 10 of 10